project id: TCGA-SKCM; case submitter id: TCGA-EE-A3AG; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.8; age at index: 25; days to birth: -9161; days to death: 1265; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1984; age at diagnosis: 9161; ajcc pathologic m: M0; ajcc pathologic n: N2c; ajcc pathologic stage: Stage III; ajcc pathologic t: T0; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 714.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 838; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-EE-A3AG-06A-31; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 85.0;